Stage III solid tumor cancer
Showing 9976 - 10000 of >10,000
Embolism and Thrombosis Trial in Canada, France (Limited cancer screening, Limited cancer screening + FDG PET/CT)
Recruiting
- Embolism and Thrombosis
- Limited cancer screening
- Limited cancer screening + FDG PET/CT
-
Calgary, Alberta, Canada
- +19 more
Feb 2, 2022
Advanced Solid Tumors Trial in Tianjin (KM501)
Not yet recruiting
- Advanced Solid Tumors
-
Tianjin, Tianjin, ChinaTianjin Cancer Hospital
Apr 5, 2023
Non Small Cell Lung Cancer Trial in Shanghai (radiochemo 1, radiochemo 2, radiochemo 3)
Completed
- Non Small Cell Lung Cancer
- radiochemotherapy 1
- +6 more
-
Shanghai, Chinathe Ethic Committee of Shanghai General Hospital
May 1, 2019
Breast Cancer, Clinically Assessed Negative Axillary Lymph Nodes, Sentinel Lymph Node Trial in Nanjing (Omit SLNB)
Recruiting
- Breast Cancer
- +2 more
- Omit SLNB
-
Nanjing, Jiangsu, Chinathe First Affiliated Hospital of Nanjing Medical University
Jul 4, 2023
NSCLC (NSCLC) Trial in United States (Calypso Beacon Implantation)
Active, not recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Calypso Beacon Implantation
-
Middletown, New Jersey
- +3 more
Jul 14, 2022
Ewing Sarcoma Trial in Warsaw (Naxitamab)
Not yet recruiting
- Ewing Sarcoma
-
Warsaw, Mazowian, PolandMother and Child Institute
Jul 28, 2023
Solid Tumor Trial in United States (Comprehensive Geriatric Assessment, Quality-of-Life Assessment, Questionnaire
Active, not recruiting
- Solid Neoplasm
- Comprehensive Geriatric Assessment
- +3 more
-
Duarte, California
- +4 more
Feb 17, 2022
Follicular Lymphoma Trial in Shanghai (lenalidomide, rituximab, parsaclisib)
Not yet recruiting
- Follicular Lymphoma
- lenalidomide
- +2 more
-
Shanghai, Shanghai, ChinaRuijin hospital, school of medicine, Shanghai jiao tong universi
May 10, 2023
Contact Lens Discomfort Trial (AZR-MD-001 ointment/semi-solid drug)
Recruiting
- Contact Lens Discomfort
- AZR-MD-001 ointment/semi-solid drug
-
Sydney, New South Wales, Australia
- +1 more
Nov 23, 2022
Head Neck Cancer Trial in Bern (Conventional follow up schedule with imaging, Deintensified follow up schedule without imaging)
Recruiting
- Head and Neck Cancer
- Conventional follow up schedule with imaging
- Deintensified follow up schedule without imaging
-
Bern, Switzerland
- +2 more
Nov 30, 2022
Metastatic Pancreatic Cancer Trial in Montpellier (GABRINOX, FOLFIRINOX)
Recruiting
- Metastatic Pancreatic Cancer
- GABRINOX
- FOLFIRINOX
-
Montpellier, Hérault, FranceInstitut régional du Cancer de Montpellier
Jan 2, 2022
Metastatic NSCLC Trial in Worldwide (Pembrolizumab, Lenvatinib, Docetaxel)
Active, not recruiting
- Metastatic Non-Small Cell Lung Cancer
- Pembrolizumab
- +2 more
-
Bakersfield, California
- +142 more
Sep 1, 2022
Bladder Cancer Trial (En bloc resection of bladder tumour)
Not yet recruiting
- Bladder Cancer
- En bloc resection of bladder tumour
- (no location specified)
Jun 24, 2022
Urinary Bladder Tumor, Transitional Cell Carcinoma, Urogenital Tumors Trial in Hall In Tirol, Salzburg (Bipolar transurethral
Recruiting
- Urinary Bladder Neoplasm
- +4 more
- Bipolar transurethral resection of bladder tumor (TURBT)
- Bipolar transurethral plasma kinetic vaporization of bladder tumor (PKVBT)
-
Hall In Tirol, Austria
- +1 more
Mar 19, 2021
Breast Cancer, Solid Tumors Trial in Boston, Grand Rapids, Houston (PF-07220060 + PF-07104091 combination dose escalation,
Recruiting
- Breast Cancer
- Solid Tumors
- PF-07220060 + PF-07104091 combination dose escalation
- +2 more
-
Grand Rapids, Michigan
- +1 more
Jun 28, 2022
Lung Cancer, Cancer of Lung, Pulmonary Cancer Trial in Atlanta (Arsenic Trioxide)
Completed
- Lung Cancer
- +4 more
- Arsenic Trioxide
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
Feb 15, 2021
Squamous Cell Carcinoma of the Head and Neck Trial in Ann Arbor (Cisplatin, Carboplatin, IMRT (Intensity-Modulated Radiation
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Cisplatin
- +3 more
-
Ann Arbor, Michigan
- +1 more
Dec 20, 2022
Advanced Solid Tumor, Lymphoma Trial in United States (ALPN-202, Pembrolizumab)
Active, not recruiting
- Advanced Solid Tumor
- Lymphoma
-
Atlanta, Georgia
- +4 more
Nov 8, 2022
Prostate Cancer, Prostate Tumor Trial in Saint Louis (HDR brachytherapy)
Recruiting
- Prostate Cancer
- Prostate Neoplasm
- HDR brachytherapy
-
Saint Louis, MissouriWashington University School of Medicine
Mar 14, 2022